Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2010 1
2013 1
2014 1
2016 1
2018 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
TRPA1 Antagonists for Pain Relief.
Koivisto A, Jalava N, Bratty R, Pertovaara A. Koivisto A, et al. Among authors: jalava n. Pharmaceuticals (Basel). 2018 Nov 1;11(4):117. doi: 10.3390/ph11040117. Pharmaceuticals (Basel). 2018. PMID: 30388732 Free PMC article. Review.
TRPA1: a transducer and amplifier of pain and inflammation.
Koivisto A, Chapman H, Jalava N, Korjamo T, Saarnilehto M, Lindstedt K, Pertovaara A. Koivisto A, et al. Among authors: jalava n. Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):50-5. doi: 10.1111/bcpt.12138. Epub 2013 Oct 7. Basic Clin Pharmacol Toxicol. 2014. PMID: 24102997 Free article. Review.
2,3-Dihydrobenzo-dioxine piperidine derivatives as potent and selective α2c antagonists.
Wang S, Haikarainen A, Pohjakallio A, Sipilä J, Kaskinoro J, Juhila S, Jalava N, Koskinen M, Vesajoki M, Kumpulainen E, Pystynen J, Koskelainen T, Holm P, Din Belle D. Wang S, et al. Among authors: jalava n. Bioorg Med Chem Lett. 2022 Aug 1;69:128783. doi: 10.1016/j.bmcl.2022.128783. Epub 2022 May 13. Bioorg Med Chem Lett. 2022. PMID: 35569686
5-HT6 receptor antagonists. Design, synthesis, and structure-activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines.
Gałęzowski M, Fabritius CH, Pesonen U, Salo H, Olszak-Płachta M, Czerwińska K, Adamczyk J, Król M, Prusis P, Sieprawska-Lupa M, Mikulski M, Kuokkanen K, Obuchowicz R, Korjamo T, Jalava N, Nikiforuk A, Nowak M. Gałęzowski M, et al. Among authors: jalava n. Bioorg Med Chem Lett. 2023 Nov 15;96:129497. doi: 10.1016/j.bmcl.2023.129497. Epub 2023 Oct 6. Bioorg Med Chem Lett. 2023. PMID: 37806499
1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.
Fabritius CH, Pesonen U, Messinger J, Horvath R, Salo H, Gałęzowski M, Galek M, Stefańska K, Szeremeta-Spisak J, Olszak-Płachta M, Buda A, Adamczyk J, Król M, Prusis P, Sieprawska-Lupa M, Mikulski M, Kuokkanen K, Chapman H, Obuchowicz R, Korjamo T, Jalava N, Nowak M. Fabritius CH, et al. Among authors: jalava n. Bioorg Med Chem Lett. 2016 Jun 1;26(11):2610-5. doi: 10.1016/j.bmcl.2016.04.024. Epub 2016 Apr 23. Bioorg Med Chem Lett. 2016. PMID: 27117428